Literature DB >> 26645976

Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.

Marco Raffaele Cosenza1, Alwin Krämer2.   

Abstract

Centrosomes, the main microtubule-organizing centers in most animal cells, are of crucial importance for the assembly of a bipolar mitotic spindle and subsequent faithful segregation of chromosomes into two daughter cells. Centrosome abnormalities can be found in virtually all cancer types and have been linked to chromosomal instability (CIN) and tumorigenesis. Although our knowledge on centrosome structure, replication, and amplification has greatly increased within recent years, still only very little is known on nature, causes, and consequences of centrosome aberrations in primary tumor tissues. In this review, we summarize our current insights into the mechanistic link between centrosome aberrations, aneuploidy, CIN and tumorigenesis. Mechanisms of induction and cellular consequences of aneuploidy, tetraploidization and CIN, as well as origin and effects of supernumerary centrosomes will be discussed. In addition, animal models for both CIN and centrosome amplification will be outlined. Finally, we describe approaches to exploit centrosome amplification, aneuploidy and CIN for novel and specific anticancer treatment strategies based on the modulation of chromosome missegregation rates.

Entities:  

Keywords:  Aneuploidy; Centrosome; Chromosomal instability

Mesh:

Year:  2016        PMID: 26645976     DOI: 10.1007/s10577-015-9505-5

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  202 in total

1.  Proteins required for centrosome clustering in cancer cells.

Authors:  Blanka Leber; Bettina Maier; Florian Fuchs; Jing Chi; Phillip Riffel; Simon Anderhub; Ludmila Wagner; Anthony D Ho; Jeffrey L Salisbury; Michael Boutros; Alwin Krämer
Journal:  Sci Transl Med       Date:  2010-05-26       Impact factor: 17.956

2.  Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells.

Authors:  Anastasia Y Kuznetsova; Katarzyna Seget; Giuliana K Moeller; Mirjam S de Pagter; Jeroen A D M de Roos; Milena Dürrbaum; Christian Kuffer; Stefan Müller; Guido J R Zaman; Wigard P Kloosterman; Zuzana Storchová
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Endomitosis of human megakaryocytes are due to abortive mitosis.

Authors:  N Vitrat; K Cohen-Solal; C Pique; J P Le Couedic; F Norol; A K Larsen; A Katz; W Vainchenker; N Debili
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

4.  TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

Authors:  Frank G Rücker; Richard F Schlenk; Lars Bullinger; Sabine Kayser; Veronica Teleanu; Helena Kett; Marianne Habdank; Carla-Maria Kugler; Karlheinz Holzmann; Verena I Gaidzik; Peter Paschka; Gerhard Held; Marie von Lilienfeld-Toal; Michael Lübbert; Stefan Fröhling; Thorsten Zenz; Jürgen Krauter; Brigitte Schlegelberger; Arnold Ganser; Peter Lichter; Konstanze Döhner; Hartmut Döhner
Journal:  Blood       Date:  2011-12-20       Impact factor: 22.113

5.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

6.  Targeting cancer cells by exploiting karyotypic complexity and chromosomal instability.

Authors:  Anna V Roschke; Ilan R Kirsch
Journal:  Cell Cycle       Date:  2005-05-25       Impact factor: 4.534

7.  Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression.

Authors:  G A Pihan; A Purohit; J Wallace; R Malhotra; L Liotta; S J Doxsey
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to subtoxic levels of S-phase-targeting anticancer drugs.

Authors:  Richard A Bennett; Hideki Izumi; Kenji Fukasawa
Journal:  Oncogene       Date:  2004-09-02       Impact factor: 9.867

9.  Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.

Authors:  Antonino B D'Assoro; Robert Busby; Kelly Suino; Emmanuella Delva; Gustavo J Almodovar-Mercado; Heidi Johnson; Christopher Folk; Daniel J Farrugia; Vlad Vasile; Franca Stivala; Jeffrey L Salisbury
Journal:  Oncogene       Date:  2004-05-20       Impact factor: 9.867

10.  Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation.

Authors:  J Ramesh Babu; Karthik B Jeganathan; Darren J Baker; Xiaosheng Wu; Ningling Kang-Decker; Jan M van Deursen
Journal:  J Cell Biol       Date:  2003-01-27       Impact factor: 10.539

View more
  25 in total

Review 1.  Centrosomes in spindle organization and chromosome segregation: a mechanistic view.

Authors:  Patrick Meraldi
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

2.  Centrosome Aberration Frequency and Disease Association in B-Acute Lymphoblastic Leukemia.

Authors:  Lily S Kerketta; Kanjaksha Ghosh; Anita Nadkarni; Manisha Madkaikar; Babu Rao Vundinti
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

3.  Energide-cell body as smallest unit of eukaryotic life.

Authors:  František Baluška; Sherrie Lyons
Journal:  Ann Bot       Date:  2018-11-03       Impact factor: 4.357

4.  Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.

Authors:  Michael J Bond; Marina Bleiler; Lauren E Harrison; Eric W Scocchera; Masako Nakanishi; Narendran G-Dayanan; Santosh Keshipeddy; Daniel W Rosenberg; Dennis L Wright; Charles Giardina
Journal:  Mol Cancer Res       Date:  2018-05-16       Impact factor: 5.852

5.  Chlamydia and HPV induce centrosome amplification in the host cell through additive mechanisms.

Authors:  Kevin Wang; Karissa J Muñoz; Ming Tan; Christine Sütterlin
Journal:  Cell Microbiol       Date:  2021-11-10       Impact factor: 3.715

6.  FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1.

Authors:  Mijung Kwon; Genesaret Rubio; Nicholas Nolan; Peter Auteri; Jean Arly Volmar; Asha Adem; Parisa Javidian; Zhongren Zhou; Michael P Verzi; Sharon R Pine; Steven K Libutti
Journal:  Cancer Res       Date:  2021-08-20       Impact factor: 12.701

7.  POC1A, prognostic biomarker of immunosuppressive microenvironment in cancer.

Authors:  Qi Zhao; Shuping Gao; Xin Chen; Xiyan Zhu
Journal:  Aging (Albany NY)       Date:  2022-06-23       Impact factor: 5.955

Review 8.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

9.  Patterns of selection against centrosome amplification in human cell lines.

Authors:  Marco António Dias Louro; Mónica Bettencourt-Dias; Claudia Bank
Journal:  PLoS Comput Biol       Date:  2021-05-12       Impact factor: 4.475

10.  Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments.

Authors:  Stacey J Scott; Xiaodun Li; Sriganesh Jammula; Ginny Devonshire; Catherine Lindon; Rebecca C Fitzgerald; Pier Paolo D'Avino
Journal:  Cell Death Differ       Date:  2021-03-01       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.